Skip to content

Incentives Targeting Gestational Weight Gain in Overweight/Obese Low Income Women

Incentives Targeting Gestational Weight Gain in Overweight/Obese Low Income Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02233673
Enrollment
136
Registered
2014-09-08
Start date
2014-03-31
Completion date
2017-08-28
Last updated
2018-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Overweight, Pregnancy

Keywords

Obesity, Pregnancy

Brief summary

Excessive weight gain during pregnancy, particularly in overweight and obese women, predisposes to adverse perinatal outcomes and has long term effects on maternal and neonatal health. With an inverse relationship between socioeconomic status and obesity, significant health disparities exist between obese and normal weight women. The Institute of Medicine (IOM) recently revised its gestational weight gain recommendations, targeted to pregravid body mass index (BMI), to minimize pregnancy complications. However, these recommendations are based on cross sectional observational studies and neither the ideal method to achieve weight gain goals nor whether perinatal outcome is optimized with active management of weight gain is known. The investigators propose to investigate a behavioral incentive-based intervention to improve compliance with IOM weight gain recommendations during pregnancy in low-income overweight and obese women. The investigators will evaluate if 1) gestational weight gain can be reliably targeted to the IOM recommendations and 2) active weight gain management during pregnancy improves perinatal outcomes. Two study groups will be compared in a prospective randomized trial; 1) those receiving standard obstetrical care and 2) those receiving behavioral weight management counseling plus financial incentives for achieving weight gain goals. The main outcome measure will be the percentage of women gaining within the IOM recommendations based on prepregnancy BMI. Secondary outcomes evaluated will include fetal growth and body composition changes, birth weight and the rate of cesarean delivery. The investigators hypothesize that 1) the behavioral intervention with incentives will result in greater compliance to IOM guidelines for gestational weight gain than standard care and 2) targeting weight gain to the IOM guidelines will lead to a reduction in the rates of fetal macrosomia and cesarean delivery. Finally, cost effectiveness of treatment conditions will be examined. This intervention, if efficacious and cost-effective, has the potential to improve compliance with gestational weight gain guidelines, optimize perinatal outcomes, and reduce health disparities.

Interventions

BEHAVIORALFinancial incentives

Participants receive a behavioral intervention and financial incentives for meeting gestational weight gain goals.

Sponsors

National Institute of General Medical Sciences (NIGMS)
CollaboratorNIH
University of Vermont
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

-≥18 years of age and ≤ 45 years of age -≤16 weeks gestation * BMI ≥25 * Ultrasound documented viable singleton intrauterine pregnancy * English speaking * Planning to deliver at Fletcher Allen Health Care * Willing to be randomized to one of the study groups * Written informed consent

Exclusion criteria

* Major fetal congenital or chromosomal anomaly * Women with a restricted diet (i.e., celiac disease, prior bariatric surgery, Phenylketonuria, or other metabolic disorder)

Design outcomes

Primary

MeasureTime frameDescription
Gestational weight gain within the Institute of Medicine guidelinesAt time of deliveryTotal gestational weight gain at time of last prenatal visit. For participants in the intervention arm, gestational weight gain at 2 week intervals will also be assessed.

Secondary

MeasureTime frameDescription
Cesarean delivery rateTime of deliveryCesarean delivery rate (as a percent of total deliveries) will be assessed
Fetal macrosomiaAt deliveryFetal weight at delivery will be recorded. Percent fetal macrosomia (birthweight \>4000g) will be assessed.

Other

MeasureTime frameDescription
Cost of interventionIntake to 6 weeks postpartumCosts to the patient attending the intervention (transportation, childcare, missed wages) will be calculated against cost differences in outcomes.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026